Datar Cancer Genetics (DCG) has launched the Target-MRD blood test, designed for the identification and monitoring of molecular residual disease (MRD) in individuals with solid organ cancers.

LONDON and MUNICH and NEW DELHI, Jan. 21, 2025 /PRNewswire/ -- Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood ...

Three female Israeli hostages held by Hamas in Gaza for 15 months have been released and brought back to Israel, after a long-awaited ceasefire deal took effect. Romi Gonen, Doron Steinbrecher ...